Cargando…
Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
The epidermal growth factor receptor variant III (EGFRvIII) is the most common variation of EGFR. Because it shows a high frequency in several different types of tumor and has not been detected in normal tissues, it is an ideal target for tumor specific therapy. In this study, we prepared EGFRvIII-H...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764640/ https://www.ncbi.nlm.nih.gov/pubmed/19788747 http://dx.doi.org/10.1186/1756-9966-28-133 |